We develop next-generation catheters that enhance patient care and create value for society.

Flex Skirt TECHNOLOGYTM

Small change.
Big difference.

Our Approach

Clinical understanding.
Scientific excellence.
Meaningful impact.

01

Research & Development

We develop next-gen urinary catheters focusing on patient safety, comfort, and clinical needs. Our experienced R&D team explores new technologies and materials to improve the quality of life for patients worldwide.

Research and development
02

Clinical Evidence

We collaborate with leading healthcare professionals to ensure that every catheter we develop is safe, effective, and backed by evidence-based research.

03

Partnerships

We believe in strong partnerships. Working closely with industry leaders, healthcare providers, and urological institutions, we accelerate innovation and bring better catheters to patients and caregivers.

Healthcare partnerships
The Problem

The cost of doing nothing

10%

affected globally by incontinence

Source: World Health Organization (WHO)

75%

of UTIs developed in hospitals are associated with a urinary catheter

Source: US Centers for Disease Control and Prevention

13,000+

deaths annually in Europe from CAUTI-related sepsis.

Source: Patient Safety Movement

Our Approch

A clear path from concept to care

In vitro

Performance is tested under controlled conditions to build early evidence and inform design development.

PHASE 01

In vivo

Selected solutions are evaluated in relevant pre-clinical models under more representative conditions.

PHASE 02

Clinical

Advanced solutions enter clinical investigation to generate evidence in the intended care setting.

PHASE 03
See product  pipeline
The need for innovation

The cost of doing nothing

Catheter-related complications can mean longer hospital stays, additional care and higher healthcare costs.

75%

Of hospital-acquired urinary tract infections are associated with a urinary catheter.

Source: CDC. Approximately 75% of UTIs developed in hospitals.

≈3 days

Additional hospital stay associated with a catheter-associated urinary tract infection.

Source: Kelly et al., 2024. Adjusted additional stay of 3.01 days in a US hospital study.

≈$14k

Estimated additional hospital cost per catheter-associated urinary tract infection in the US.

Source: AHRQ, 2017. Estimated additional cost of $13,793 per CAUTI; not a current-price estimate.

20%

Of unscheduled out-of-hours community nursing visits were catheter-related in one study.

Source: Mackay et al., 2018. Findings from a community nursing study; not a universal rate.

A new approach to urinary drainage.

NowCath Foley

Explore NowCath
Close-up of the flexible skirt integrated into the NowCath catheter.
Flex Skirt Technology™
Nowwell — Designed for life
Se how it works
The Problem

The cost of doing nothing

10%
affected globally by incontinence
Source: World Health Organization (WHO)
75%
of UTIs developed in hospitals are associated with a urinary catheter
Source: US Centers for Disease Control and Prevention
13.000+
deaths annually in Europe from CAUTI-related sepsis.
Source: Patient Safety Movement

Designed for life

Our purpose is to enhance dignity and quality of life for people
living with urinary incontinence and retention.

Clinical investigation

The REDUCE trial

Evaluating NowCath Foley in adults using long-term indwelling urinary catheters.

Explore the trial
An older adult looking out of a window.
CHRONIC & ACUTE CARE

NowCath Foley

NowCath Foley is the first product to integrate Flex Skirt Technology. It is currently being evaluated in the REDUCE clinical trial.

A three-quarter view of the soft, flexible skirt.
An older couple embracing outdoors beneath a blue sky.
About us

It started with someone close.

Nowwell was founded to rethink the urinary catheter from the ground up. Independent in our thinking. Scientific in our approach. Collaborative by nature.

Get to know Nowwell
Introducing NowCath Foley

Rethinking catheter care.

Meet NowCath Foley. A familiar form. A different approach.

NowCath Foley catheter product render

NowCath Foley · Featuring Flex Skirt Technology™

An older couple sharing a moment outdoors

Life beyond the catheter.

The reason we keep asking what could be better.

Clinical investigation

Good questions deserve evidence.

The REDUCE trial is evaluating NowCath Foley in adults using long-term indwelling urinary catheters.

Explore the REDUCE trial

An investigation of the technology—not a statement of proven clinical benefit.

An older adult looking out of a windowResearch with people at its heart.
Our pipeline

NowCath is a beginning.

Explore the catheter technologies we are developing—and the thinking that connects them.

Discover our pipeline
Detail of the flexible catheter skirt
Softly focused silhouettes in a warm office setting
About Nowwell

Different perspectives. Shared purpose.

Meet the people and purpose behind our approach to urinary care.

Get to know Nowwell
News & perspectives

The latest from Nowwell.

Visit the newsroom
Let’s talk

Good things start
with a conversation.

Interested in our work? We’d like to hear from you.

Contact us

The latest from Nowwell

Visit newsroom